The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants

Show other versions (1)

<p>Farnesyl pyrophosphate synthase (FPPS) is the major molecular target of nitrogen-containing bisphosphonates (N-BPs), used clinically as bone resorption inhibitors. We investigated the role of threonine 201 (Thr201) and tyrosine 204 (Tyr204) residues in substrate binding, catalysis and inhib...

Full description

Bibliographic Details
Main Authors:	Tsoumpra, MK, Muniz, JR, Barnett, BL, Kwaasi, AA, Pilka, ES, Kavanagh, KL, Evdokimov, A, Walter, RL, Von Delft, F, Ebetino, FH, Oppermann, U, Russell, RGG, Dunford, JE
Format:	Journal article
Language:	English
Published:	Elsevier 2015

Similar Items

The Role of Active Site Threonine 201 in the Inhibition of Farnesyl Pyrophosphate Synthase by Nitrogen Containing Bisphosphonates
by: Dunford, J, et al.
Published: (2008)

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.
by: Tsoumpra, M, et al.
Published: (2015)

Interaction of the active site threonine 201 sidechain with the nitrogen of nttrogen-containing bisphosphonates is not essential for slow tight inhibition to farnesyl pyrophosphate synthase
by: Dunford, J, et al.
Published: (2008)

Evidence for the involvement of the threonine 201 side-chain in the interaction of nitrogen-containing bisphosphonates with farnesyl pyrophosphate synthase
by: Kwassi, A, et al.
Published: (2009)

The interaction of sidechain nitrogen with active site threonine is not essential for inhibition of farnesyl pyrophosphate synthase by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2008)

Designed mutants of human farnesyl pyrophosphate synthase (FPPS) help to characterise the interactions of nitrogen-containing bisphosphonates with Tyrosine 204 and Phenylalanine 239 side-chain residues
by: Tsoumpra, M, et al.
Published: (2010)

Analysis of the kinetic mechanism of inhibition of Farnesyl Pyrophosphate Synthase by nitrogen containing bisphosphonates.
by: Dunford, J, et al.
Published: (2006)

Structure activity relationships of nitrogen containing bisphosphonates which induce conformational changes in farnesyl pyrophosphate synthase
by: Dunford, J, et al.
Published: (2008)

Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
by: Dunford, J, et al.
Published: (2008)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2007)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2007)

The mode of binding of nitrogen containing bisphosphonates in farnesyl pyrophosphate synthase
by: Ebetino, F, et al.
Published: (2007)

MEDI 73-Modeling, synthetic, crystallographic, and activity studies of novel bisphosphonates as inhibitors of farnesyl pyrophosphate synthase
by: Hogan, J, et al.
Published: (2007)

Investigations into the kinetic mechanism of inhibition of farnesyl diphosphate synthase by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2006)

Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy
by: Lundy, M, et al.
Published: (2007)

A mirror image pair of bisphosphonate analogs further demonstrates the mode of binding of the bisphosphonates in farnesyl pyrophosphate synthase
by: Ebetino, F, et al.
Published: (2008)

Human farnesyl diphosphate synthase crystal structures with active and inactive bisphosphonates
by: Evdokimov, A, et al.
Published: (2006)

Human farnesyl diphosphate synthase (FDFS): Crystal structure and molecular interactions with Nnitrogen-containing bisphosphonates.
by: Kavanagh, K, et al.
Published: (2005)

Molecular modeling comparison of nitrogen-containing bisphosphonates of varying potency co-crystalized in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2006)

Modeling of bisphosphonate binding to farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2002)

Molecular modeling comparison of nitrogen-containing bisphosphonates of varying potency co-crystalized in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2006)

Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2005)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
by: Mabilleau, G, et al.
Published: (2010)

Stereochemical evidence of the mode of binding of nitrogen containing bisphosphonates in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2007)

Predicting the clinical potencies of bisphosphonates: Divergence of hydroxyapatite and farnesyl diphosphate synthase binding affinities
by: Xia, Z, et al.
Published: (2007)

Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells
by: Räikkönen, J, et al.
Published: (2011)

Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
by: Räikkönen, J, et al.
Published: (2011)

New anti-candida active nitrogen-containing bisphosphonates as inhibitors of farnesyl pyrophosphate synthase Candida albicans
by: L. O. Metelytsia, et al.
Published: (2019-05-01)

Molecular modeling of the bisphosphonates (BPs) in farnesyl diphosphate (FPP) synthase. Proposed new mechanism of inhibition by potent nitrogen containing bisphosphonates (NBPs).
by: Ebetino, F, et al.
Published: (2002)

Molecular modeling of the bisphosphonates in farnesyl diphosphate synthase. potential new details of the precise biochemical mechanism of action of potent nitrogen containing bisphosphonates
by: Ebetino, F, et al.
Published: (2002)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
by: Kavanagh, K, et al.
Published: (2006)

The relationship between the chemistry and biological activity of the bisphosphonates.
by: Ebetino, F, et al.
Published: (2011)

Nitrogen-containing bisphosphonates of varying antiresorptive potency have been co-crystallized in farnesyl diphosphate synthase and modelled to understand the key structural features involved in enzyme inhibition.
by: Ebetino, F, et al.
Published: (2006)

Inhibition of human mevalonate kinase by allosteric inhibitors of farnesyl pyrophosphate synthase
by: Saman Salari, et al.
Published: (2024-08-01)

Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii.
by: Yu-Jun Zhao, et al.
Published: (2015-01-01)

Refining structure activity relationships among nitrogen containing bisphosphonates: Dissociation of mineral binding affinity and inhibitory potency on farnesyl diphosphate synthase.
by: Xia, Z, et al.
Published: (2006)

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
by: Kavanagh, K, et al.
Published: (2006)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
by: Russell, R, et al.
Published: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
by: Russell, R, et al.
Published: (2007)

Farnesyl pyrophosphate is a new danger signal inducing acute cell death.
by: Jing Chen, et al.
Published: (2021-04-01)